Premium
Re‐treating chronic hepatitis C with daily interferon alfacon‐1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective?
Author(s) -
Lo GinHo
Publication year - 2009
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.23125
Subject(s) - ribavirin , discontinuation , medicine , pegylated interferon , gastroenterology , hepatitis c virus , adverse effect , interferon , hepatitis c , chronic hepatitis , alpha interferon , immunology , virology , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom